Shintaro Narita

35PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Comparative language studies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 15, 2026
Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

|May 31, 2026
Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

|Mar 23, 2026
Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.

Masanao Shinohara, Hayato Yamamoto, Yohei Kawashima

|Jan 24, 2026
Triplet therapy versus androgen receptor pathway inhibitor-doublet therapy in metastatic castration-sensitive prostate cancer: a real-world multicenter retrospective comparison.

Fumihiko Urabe, Takafumi Yanagisawa, Wataru Fukuokaya

|Dec 13, 2025
Androgen-Deprivation Therapy and Dietary Habits Influence the Gut Microbial Environment in Patients With High-Risk Localized Prostate Cancer.

Masanori Ishida, Shintaro Narita, Hiromi Sato

|Nov 25, 2025
Consensus Meeting of Anatomy on the Border, Appropriate Use and Precautions for ICG in Liver, Lung, and Renal Surgery.

Junji Ichinose, Shinji Itoh, Shintaro Narita

Pageof 6

Frequent Collaborators

8 joint publications

Shingo Hatakeyama

6 joint publications

Kazuyuki Numakura

4 joint publications

Takahiro Kimura

3 joint publications

Masaki Shiota